Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04098250 · ClinicalTrials.gov registry record · Phase 2

Multidisciplinary Translational Approach to Investigate Mechanisms Predictors & Prevention of Persistent PTH

A Phase 2 study of Post-Traumatic Headache, sponsored by Mayo Clinic.

Completed
Registry status
Phase 2
Development phase
6
Enrollment target
5
Study locations

NCT04098250 is a Phase 2 study of Post-Traumatic Headache that has completed, run by Mayo Clinic. The registered enrollment target is 6 participants, below the 100-participant average among 8 other Post-Traumatic Headache trials with a reported enrollment target (94% lower). The trial reports 5 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04098250, a Phase 2 study of Post-Traumatic Headache, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
Phase 2
Development phase
6 participants
Enrollment target
5
Study locations

Study Summary

This is a United States Department of Defense funded Focused Program study that aims to identify mechanisms and predictors for persistent of post-traumatic headache attributed to mild traumatic brain injury, and identify methods of preventing post-traumatic headache persistence. The objective of the clinical trial component of the Focused Program is to determine whether intervention with erenumab is an effective treatment for PTH attributed to mTBI.

Conditions Studied

Interventions

  • OTHER Placebo
  • DRUG Erenumab

Study Locations (5)

Arizona

  • Phoenix VA Health Care System - Phoenix
  • Mayo Clinic - Phoenix
  • Mayo Clinic in Arizona - Scottsdale

Florida

  • Mayo Clinic - Jacksonville

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2021-01-04
Est. Completion 2024-01-10
Phase Phase 2

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT04098250

The ClinicalTrials.gov registry entry for NCT04098250 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 100-participant average among 8 other Post-Traumatic Headache trials with a reported enrollment target (94% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Post-Traumatic Headache appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT04098250 reports 5 study locations spanning 3 distinct geographic areas - top geographies include Arizona, Florida, Minnesota.

Frequently Asked Questions

What is clinical trial NCT04098250 about?

NCT04098250 is a clinical study titled "Multidisciplinary Translational Approach to Investigate Mechanisms Predictors & Prevention of Persistent PTH". This is a United States Department of Defense funded Focused Program study that aims to identify mechanisms and predictors for persistent of post-traumatic headache attributed to mild traumatic brain injury, and identify methods of preventing post-traumatic headache persistence. The objective of th...

What is the current status of trial NCT04098250?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2021-01-04. Estimated completion is 2024-01-10.

What conditions does trial NCT04098250 study?

This clinical trial studies the following conditions: Post-Traumatic Headache.

What interventions are being tested in trial NCT04098250?

The interventions under investigation include: Placebo (OTHER), Erenumab (DRUG).

Who is sponsoring clinical trial NCT04098250?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04098250 being conducted?

This trial has 5 study locations across Arizona, Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post-Traumatic Headache

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.